MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ALPS Medical Breakthroughs ETF (NY:SBIO)

50.18 -1.52 (-2.94%)
Official Closing Price Updated: 8:00 PM EDT, Mar 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 26,122
Open 50.95
Bid (Size) 50.20 (10,000)
Ask (Size) 50.36 (200)
Prev. Close 51.70
Today's Range 49.72 - 51.01
52wk Range 22.33 - 54.79
Shares Outstanding 24,000
Dividend Yield 2.34%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
QURE Jumps 20% – Analysts Upgrade Stock On Huntington’s Disease Therapy Update, Retail Eyes $150 ↗
Wells Fargo upgraded uniQure’s stock to ‘Overweight,’ citing a bullish outlook for its gene therapy following reports that Vinay Prasad will leave the U.S. FDA next month. 
Via Stocktwits
News headline image
AARD Stock Slumps 54% Pre-Market – Here’s Why Analysts Are Not ‘Comfortable’ With The Suspension Of A Key Phase 3 Trial ↗
Aardvark Therapeutics shares saw brokerage downgrades after the company paused its Phase 3 trial to treat hyperphagia in patients with Prader-Willi syndrome. 
Via Stocktwits

Performance

YTD
+0.0%
+0.0%
1 Month
-2.4%
-2.4%
3 Month
-1.8%
-1.8%
6 Month
+36.3%
+36.3%
1 Year
+62.0%
+62.0%

More News

Read More
News headline image
Why Did NGNE Stock Surge 25% In Pre-Market Today? ↗
Via Stocktwits
MLTX Stock Extends Rally As FDA Feedback Spurs Bullish Brokerage Action – Retail Speculates On Potential M&A Conversations ↗
Via Stocktwits
News headline image
Vanda Pharma Stock Rises Pre-Market After FDA Accepts Imsidolimab Filing For Rare Skin Disorder ↗
Via Stocktwits
News headline image
Why Did MLTX Stock Jump 45% In Pre-Market Today? ↗
Via Stocktwits
News headline image
Capricor’s Red-Hot Rally Has Wall Street And Retail Hooked — And Fresh DMD Data Could Keep Fueling The Fire ↗
Via Stocktwits
News headline image
Compass Pathways Stock Slumps After Positive Late-Stage Trial Results From Psychedelic Drug ‘Underwhelm’ Analysts ↗
Via Stocktwits
News headline image
Autolus Therapeutics Gets Favorable Recommendation For Approval Of Cancer Therapy In EU: Retail Sentiment Brightens ↗
Via Stocktwits
Topics Artificial Intelligence
News headline image
Galapagos Announces CFO Exit With No Successor Named Yet: Retail’s Disappointed ↗
Via Stocktwits
Topics Earnings
News headline image
Goldman Sachs Thinks Mid-Cap Biotech MoonLake Could Soar Over 80%: Is Retail Watching Closely? ↗
Via Stocktwits
News headline image
5 Small-Cap ETFs At The Forefront Of The Latest Rally ↗
Via Talk Markets
Topics ETFs
News headline image
The Short-Term Trend Is Uncertain, But Stocks Are Showing Momentum ↗
Via Talk Markets
News headline image
5 Market-Beating Sector ETFs Of December ↗
Via Talk Markets
Topics ETFs Economy
News headline image
5 Top-Performing Sector ETFs Of Q2 ↗
Via Talk Markets
News headline image
Biotech ETFs Pop On M&A Resurgence ↗
Via Talk Markets
News headline image
5 Sector ETFs That Beat the Market in Apri ↗
Via Talk Markets
News headline image
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector ↗
Via InvestorPlace
News headline image
5 ETFs Riding High On The Biotech Comeback ↗
Via Talk Markets
News headline image
7 Best Biotech Stocks to Buy in July 2022 ↗
Via InvestorPlace
News headline image
Biotech ETFs That Outperformed Last Week ↗
Via Talk Markets
News headline image
Psychedelics Company COMPASS Pathways To Join NASDAQ Biotechnology Index ↗
Via Benzinga
News headline image
Top-Performing Biotech ETFs of Last Week ↗
Via Talk Markets
News headline image
5 Small-Cap Sector ETFs Leading the Russell 2000 Rally ↗
Via Talk Markets
News headline image
Medical Miracles Inside Biotech ETFs ↗
Via Talk Markets
Topics Intellectual Property

Frequently Asked Questions

Is ALPS Medical Breakthroughs ETF publicly traded?
Yes, ALPS Medical Breakthroughs ETF is publicly traded.
What exchange does ALPS Medical Breakthroughs ETF trade on?
ALPS Medical Breakthroughs ETF trades on the New York Stock Exchange
What is the ticker symbol for ALPS Medical Breakthroughs ETF?
The ticker symbol for ALPS Medical Breakthroughs ETF is SBIO on the New York Stock Exchange
What is the current price of ALPS Medical Breakthroughs ETF?
The current price of ALPS Medical Breakthroughs ETF is 50.18
When was ALPS Medical Breakthroughs ETF last traded?
The last trade of ALPS Medical Breakthroughs ETF was at 03/12/26 08:00 PM ET
What is the market capitalization of ALPS Medical Breakthroughs ETF?
The market capitalization of ALPS Medical Breakthroughs ETF is 1.20M
How many shares of ALPS Medical Breakthroughs ETF are outstanding?
ALPS Medical Breakthroughs ETF has 1M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story